Mariner, LLC Deciphera Pharmaceuticals, Inc. Transaction History

Mariner, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$14.85 - $19.04 $77,591 - $99,484	5,225 Added 21.66%	29,352 $481,000
Q3 2022 Nov 10, 2022	SELL	$12.38 - $20.23 $6,462 - $10,560	-522 Reduced 2.12%	24,127 $446,000
Q2 2022 Aug 15, 2022	BUY	$9.11 - $13.98 $19,832 - $30,434	2,177 Added 9.69%	24,649 $324,000
Q1 2022 May 13, 2022	BUY	$6.87 - $11.11 $9,624 - $15,565	1,401 Added 6.65%	22,472 $208,000
Q4 2021 Feb 14, 2022	BUY	$7.7 - $37.13 $162,246 - $782,366	21,071 New	21,071 $206,000

293K

500

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

Get notified when there are updates to the investment portfolio of Mariner, LLC, based on Form 13F filings with the SEC.

Stay updated on Mariner, LLC with notifications on news.